Hjem
Beskrivelse
Ambrilia Biopharma Inc. (TSX:AMB) is a biopharmaceutical company developing innovative therapeutics in the fields of oncology and infectious diseases. Ambrilia.s broad pipeline includes proprietary mid to early-stage products and two specialty generics.
Timeline
{{companyName}} {{title}}
Visit our website @ {{website}}
{{companyName}} {{title}}
Our new location address:
{{street}}, {{city}}, {{state}}, {{postalCode}}, {{country}}
{{companyName}} {{title}}
{{companyName}} {{title}}
{{name}}
{{description}}